HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


LVMH financials

This article was originally published in The Rose Sheet

Executive Summary

Perfumes & Cosmetics division sales gain 7.3% to $550.2 mil. (€1=$.98) in third quarter due to successful launch of Christian Dior women's scent Dior Addict and roll out of Givenchy Pour Homme and Eau Torride fragrances, luxury goods manufacturer says. Double-digit sales growth at BeneFit Cosmetics and Fresh also helped to fuel sales, firm adds in its 1third quarter sales and earnings release Oct. 15. Sales in the Selective Retailing division, which includes Sephora and duty-free sales, fell 7.4% to $782.8 mil., due to slow recovery in travel retail, LVMH notes. In the U.S., Sephora recorded a 32% sales gain for the nine months, and Perfumes & Cosmetics division sales increased 6% in the region. Consolidated sales increased 2.2% to $8.68 bil. for first nine months of the year...

You may also be interested in...

Basilea Stresses Derazantinib's FGFR Kinase Differentiation

Switzerland’s SIX exchange-listed drug development company, Basilea, is moving two new oncology candidates along its R&D pipeline, supported by strong revenues from two partnered anti-infective products.


ATMPs Put EU Cross-Border Healthcare On The Map

Recommendations from the Alliance for Regenerative Medicine aim to improve cross-border healthcare to ensure patients can access advanced therapies.

Start-Up Snapshot: Nanomedic’s Electro-Spinning, Portable Wound Care Device

At the OurCrowd Global Investor Summit in Jerusalem, Israel, on 13 February, Medtech Insight met wound care device company Nanomedic to find out more about its unique electro-spinning technology.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts